Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 3]
This is a Phase 3 clinical trial evaluating vedolizumab in children with ulcerative colitis or Crohn's disease; recruitment is currently ong…
-
CLINICAL_TRIALS other · 2026-04-16Clinical Trial Update: Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease [NA]
Clinical trial evaluating multi-strain probiotics for children and adolescents with inflammatory bowel disease. The study status is NOT_YET_…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Patient Preference for Subcutaneous vs. Intravenous Immune Therapy [Phase 2]
Phase 2 clinical trial update on patient preference for subcutaneous versus intravenous immune therapy; the study is currently recruiting ac…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis [NA]
A clinical trial is examining ketogenic and carnivore diets for inflammatory bowel disease and rheumatoid arthritis, and the study is curren…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis [Phase 4]
This is a Phase 4 trial evaluating Upadacitinib in hospitalized patients with acute severe ulcerative colitis; the study is currently not ye…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-04-15FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab submitted by Janssen Biotech, Inc. The action pertains to a supplemental submission …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Immunological Characteristics of Preclinical IBD
This clinical trial update describes a preclinical study examining the immunological characteristics of inflammatory bowel disease, includin…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Pentoxifylline in Patients With Ulcerative Colitis [Phase 2]
Phase 2 clinical trial evaluating pentoxifylline for ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
This entry describes a real-world outcomes study evaluating long-term guselkumab use in inflammatory bowel diseases, focusing on ulcerative …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission [Phase 4]
Phase 4 clinical trial update assessing withdrawal of immunosuppressant therapy in elderly ulcerative colitis patients in long-term remissio…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Fecal Microbiome Transplant [Phase 1]
This is a Phase 1 clinical trial update on fecal microbiome transplantation that is currently enrolling by invitation for patients with Clos…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFα Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis,
A pediatric clinical trial evaluating outcomes for children with Crohn's disease or ulcerative colitis after switching from anti-TNF therapy…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating MB-001 for moderately to severely active ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]
This Phase 2 clinical trial update reports completion of the study of JNJ-77242113 in participants with moderately to severely active ulcera…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 clinical trial evaluating guselkumab in pediatric participants with moderately to severely active ulcerative colitis. The study is c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]
This update covers a Phase 2 study evaluating the combination of guselkumab and golimumab in participants with moderately to severely active…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis [Phase 1, Phase 2]
This entry describes a Phase 1/Phase 2 clinical trial evaluating XmAb942 in healthy participants and in individuals with ulcerative colitis.…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Long-term Extension Study of Ustekinumab in Pediatric Participants [Phase 3]
Long-term extension Phase 3 trial of ustekinumab in pediatric patients is being conducted for Crohn's disease and ulcerative colitis, with a…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
A clinical trial is assessing the long-term safety of ustekinumab compared with other biologics in patients with Crohn's disease and ulcerat…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea
This document reports on an observational database study in Korea examining disease patterns, treatment approaches, and healthcare utilizati…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial is evaluating the safety of TAK-279 and its potential to reduce bowel inflammation in moderately to severely active…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
This clinical trial update describes a real-world study of guselkumab in Chinese participants with ulcerative colitis, which is currently re…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants [Phase 3]
A long-term extension study of guselkumab in pediatric participants with Crohn's disease, ulcerative colitis, psoriatic arthritis, and juven…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Naturopathic Approaches to Ulcerative Colitis
This clinical trial update describes naturopathic approaches being studied for Ulcerative Colitis. The study is currently NOT_YET_RECRUITING…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
This clinical trial update notes a study evaluating ozanimod for steroid-dependent ulcerative colitis, which is currently recruiting.